Galera Therapeutics, Inc. Common Stock

GRTX

...

GRTX: Galera Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer. Its lead product candidate, GC4419, is a small molecule dismutase mimetic developed for the reduction of severe oral mucositis, or SOM.

Show GRTX Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of GRTX by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by GRTX's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

Patent Title: Chromatography of metal complexes Aug. 19, 2014
Patent Title: Super-oxide dismutase mimetics Jul. 16, 2013
Patent Title: Chromatography of metal complexes May. 21, 2013
Patent Title: Chromatography of metal complexes Sep. 11, 2012
Patent Title: Polyethylene glycolated superoxide dismutase mimetics Jul. 10, 2012

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on GRTX's company Twitter account

WallStreetBets

Number of mentions of GRTX in WallStreetBets Daily Discussion

GRTX News

Recent insights relating to GRTX

CNBC Recommendations

Recent picks made for GRTX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GRTX

Corporate Flights

Flights by private jets registered to GRTX